Psoriasis Pipeline Review, H1 Market 2016 Size, Share, Trends and Forecast 2016

Submitted by: Submitted by

Views: 10

Words: 449

Pages: 2

Category: Business and Industry

Date Submitted: 05/23/2016 12:12 AM

Report This Essay

Psoriasis Market Size, Share, Analysis and Causes, Symptoms, Treatment, Pipeline Review, H1 2016

Global Markets Direct's, ‘Psoriasis - Pipeline Review, H1 2016', provides an overview of the Psoriasis pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Psoriasis, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development for Psoriasis and features dormant and discontinued projects.

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources.

Browse Detail Report With TOC @ http://www.radiantinsights.com/research/psoriasis-pipeline-review-h1-2016

Scope

The report provides a snapshot of the global therapeutic landscape of Psoriasis

The report reviews pipeline therapeutics for Psoriasis by companies and universities/research institutes based on information derived from company and industry-specific sources

Table of Content

Table of Contents 2

Introduction 9

Browse Upcoming Reports @ http://www.radiantinsights.com/upcoming-reports

Psoriasis Overview 10

Therapeutics Development 11

Psoriasis - Therapeutics under Development by Companies 13

Psoriasis - Therapeutics under Investigation by Universities/Institutes 26

Psoriasis - Pipeline Products Glance 27

Psoriasis...